EDG-6 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of EDG-6 monoclonal antibodies for research focused on understanding EDG-6 protein functions. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EDG-6, also known as S1P receptor 3, belongs to the endothelial differentiation gene family and mediates cellular responses to sphingosine-1-phosphate (S1P). EDG-6 influences cell proliferation, migration, and survival pathways, making it relevant in both normal physiology and disease states. Research has shown EDG-6's significance in cancer development, cardiovascular function, and immune system regulation. Scientists can utilize EDG-6 monoclonal antibodies to advance their understanding of cellular signaling mechanisms and disease progression. Investigating EDG-6 expression and activity patterns provides valuable insights into potential therapeutic targets. The reliability and specificity of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to scientific knowledge and therapeutic development.